PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2026-03-04 (6)

Date Title Company
04-Mar-2026 Seaport Therapeutics and Monash Institute of Pharmaceutical Sciences Awarded up to $15 Million from ARPA‑H to Advance Seaport’s GlyphCele™, the First Oral Therapeutic Designed to Restore Gut Lymphatic Function Businesswire